174 related articles for article (PubMed ID: 10858286)
61. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.
Flores-Rozas H; Kelman Z; Dean FB; Pan ZQ; Harper JW; Elledge SJ; O'Donnell M; Hurwitz J
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8655-9. PubMed ID: 7915843
[TBL] [Abstract][Full Text] [Related]
62. Rational Design of a 3
Wegener KL; McGrath AE; Dixon NE; Oakley AJ; Scanlon DB; Abell AD; Bruning JB
Chemistry; 2018 Aug; 24(44):11325-11331. PubMed ID: 29917264
[TBL] [Abstract][Full Text] [Related]
63. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
Waga S; Hannon GJ; Beach D; Stillman B
Nature; 1994 Jun; 369(6481):574-8. PubMed ID: 7911228
[TBL] [Abstract][Full Text] [Related]
64. PCNA binding proteins in Drosophila melanogaster : the analysis of a conserved PCNA binding domain.
Warbrick E; Heatherington W; Lane DP; Glover DM
Nucleic Acids Res; 1998 Sep; 26(17):3925-32. PubMed ID: 9705499
[TBL] [Abstract][Full Text] [Related]
65. Stimulation of eukaryotic flap endonuclease-1 activities by proliferating cell nuclear antigen (PCNA) is independent of its in vitro interaction via a consensus PCNA binding region.
Frank G; Qiu J; Zheng L; Shen B
J Biol Chem; 2001 Sep; 276(39):36295-302. PubMed ID: 11477073
[TBL] [Abstract][Full Text] [Related]
66. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
67. Involvement of the proliferating cell nuclear antigen (PCNA) in DNA repair induced by alkylating agents and oxidative damage in human fibroblasts.
Savio M; Stivala LA; Bianchi L; Vannini V; Prosperi E
Carcinogenesis; 1998 Apr; 19(4):591-6. PubMed ID: 9600342
[TBL] [Abstract][Full Text] [Related]
68. Crystal structures of the Arabidopsis thaliana proliferating cell nuclear antigen 1 and 2 proteins complexed with the human p21 C-terminal segment.
Strzalka W; Oyama T; Tori K; Morikawa K
Protein Sci; 2009 May; 18(5):1072-80. PubMed ID: 19388052
[TBL] [Abstract][Full Text] [Related]
69. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation.
Asada M; Yamada T; Ichijo H; Delia D; Miyazono K; Fukumuro K; Mizutani S
EMBO J; 1999 Mar; 18(5):1223-34. PubMed ID: 10064589
[TBL] [Abstract][Full Text] [Related]
70. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
Qin LF; Ng IO; Fan ST; Ng M
Int J Cancer; 1998 Aug; 79(4):424-8. PubMed ID: 9699537
[TBL] [Abstract][Full Text] [Related]
71. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
72. Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners.
Frouin I; Maga G; Denegri M; Riva F; Savio M; Spadari S; Prosperi E; Scovassi AI
J Biol Chem; 2003 Oct; 278(41):39265-8. PubMed ID: 12930846
[TBL] [Abstract][Full Text] [Related]
73. [E1A oncogene effect on the ability of p21(Waf1) to regulate G1/S arrest in E1A-expressing transformants following irradiation].
Romanov VS; Brichkina AI; Pospelov VA; Pospelova TV
Tsitologiia; 2005; 47(12):1063-70. PubMed ID: 16706194
[TBL] [Abstract][Full Text] [Related]
74. An interaction between DNA ligase I and proliferating cell nuclear antigen: implications for Okazaki fragment synthesis and joining.
Levin DS; Bai W; Yao N; O'Donnell M; Tomkinson AE
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12863-8. PubMed ID: 9371766
[TBL] [Abstract][Full Text] [Related]
75. Distinct pools of proliferating cell nuclear antigen associated to DNA replication sites interact with the p125 subunit of DNA polymerase delta or DNA ligase I.
Riva F; Savio M; Cazzalini O; Stivala LA; Scovassi IA; Cox LS; Ducommun B; Prosperi E
Exp Cell Res; 2004 Feb; 293(2):357-67. PubMed ID: 14729473
[TBL] [Abstract][Full Text] [Related]
76. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer.
Bahl R; Arora S; Nath N; Mathur M; Shukla NK; Ralhan R
Oncogene; 2000 Jan; 19(3):323-8. PubMed ID: 10656678
[TBL] [Abstract][Full Text] [Related]
77. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription.
Kitaura H; Shinshi M; Uchikoshi Y; Ono T; Iguchi-Ariga SM; Ariga H
J Biol Chem; 2000 Apr; 275(14):10477-83. PubMed ID: 10744738
[TBL] [Abstract][Full Text] [Related]
78. In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair.
Gramantieri L; Trerè D; Chieco P; Lacchini M; Giovannini C; Piscaglia F; Cavallari A; Bolondi L
J Hepatol; 2003 Dec; 39(6):997-1003. PubMed ID: 14642618
[TBL] [Abstract][Full Text] [Related]
79. DNA ligase I is recruited to sites of DNA replication by an interaction with proliferating cell nuclear antigen: identification of a common targeting mechanism for the assembly of replication factories.
Montecucco A; Rossi R; Levin DS; Gary R; Park MS; Motycka TA; Ciarrocchi G; Villa A; Biamonti G; Tomkinson AE
EMBO J; 1998 Jul; 17(13):3786-95. PubMed ID: 9649448
[TBL] [Abstract][Full Text] [Related]
80. Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction.
Prabhu NS; Blagosklonny MV; Zeng YX; Wu GS; Waldman T; El-Deiry WS
Clin Cancer Res; 1996 Jul; 2(7):1221-9. PubMed ID: 9816291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
